UCP2 mRNA expression level of leukocyte was significantly reduced in HD patients (0.047±0.0018, P = 0.011) compared with preHD carriers (0.065±0.0070) and the controls (0.058±0.0029). This evidence concerns the gene UCP2 and Huntington disease.